Our research teams conduct innovative research into gastro-intestinal (GI) cancers spanning the digestive tract, including:
- Upper aero-digestive tumours (head and neck)
- Oesophageal and stomach cancers
- Hepatobiliary tract tumours, including pancreatic cancer
- Small intestine adenocarcinoma
- Colorectal (bowel) cancer
Our GI research aims to reduce the likelihood of cancer progression and improve survival through:
- Identifying ways to personalize treatment so that the most effective treatment is given to individual patients, while other patients are prevented from unnecessary harm
- Discovery and clinical testing of new treatments that are resistant to our current treatments
- Identifying post-treatment factors, including lifestyle factors, that could improve survival or quality of life for GI cancer patients
- Better understanding of the biological mechanisms driving early and late-stage GI cancer, so as to inform treatment strategies.
Our researchers focusing on GI cancers are drawn from a range of disciplines: scientists, clinicians, epidemiologists, pathologists and bioinformaticians. Our interdisciplinary approach focusses on collaborative research between lab-based and data scientists, and clinical triallists, allowing for close working relationships between our researchers and clinicians.